HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary N-methylhistamine in asthmatic children receiving azelastine hydrochloride.

AbstractBACKGROUND:
Histamine has a particular role in the pathogenesis of bronchial asthma, and many antiallergic drugs have been developed with antihistaminic action in mind. Recently, a sensitive and specific assay for measuring histamine and its metabolites has been developed. There are, however, no reports of the effect of antiallergic drugs on histamine levels in asthmatic patients.
OBJECTIVES:
To determine the relationship between clinical symptoms and histamine levels in asthmatic patients receiving an antiallergic agent.
METHODS:
A prospective study was designed in asthmatic children treated with azelastine hydrochloride. The evaluation of clinical symptoms was based on scores of the severity of exacerbations, activities of daily living, quality of sleep, and required therapy. Urinary excretion of N-methylhistamine, a major metabolite of histamine, was measured by double antibody radioimmunoassay.
RESULTS:
In the patients treated with azelastine, the improvement in clinical symptoms of bronchial asthma correlated significantly with a decrease in urinary N-methylhistamine excretion (r2 = 0.434, P < .001), while no such relationship was noted in patients receiving no antiallergic agent. Urinary N-methylhistamine excretion showed no diurnal change or influence of meals.
CONCLUSIONS:
Decreased urinary N-methylhistamine excretion may be a direct reflection of the antihistaminic action of azelastine in vivo. Measurement of urinary N-methylhistamine excretion can be used to evaluate the efficacy of agents with antihistaminic action in the treatment of bronchial asthma.
AuthorsS Takei, A Shimago, M Iwashita, T Kumamoto, K Kamuro, K Miyata
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 78 Issue 5 Pg. 492-6 (May 1997) ISSN: 1081-1206 [Print] United States
PMID9164363 (Publication Type: Journal Article)
Chemical References
  • Anti-Allergic Agents
  • Histamine Antagonists
  • Methylhistamines
  • Phthalazines
  • N-methylhistamine
  • azelastine
Topics
  • Anti-Allergic Agents (administration & dosage, therapeutic use)
  • Asthma (drug therapy, urine)
  • Child
  • Child, Preschool
  • Circadian Rhythm
  • Dose-Response Relationship, Drug
  • Female
  • Histamine Antagonists (therapeutic use)
  • Humans
  • Infant
  • Male
  • Methylhistamines (urine)
  • Phthalazines (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: